UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

Journal of clinical oncology, 2012-02, Vol.30 (4), p.387-393

2012

Volltextzugriff (PDF)

Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis

British journal of haematology, 2024-05, Vol.204 (5), p.1888-1893

2024

Volltextzugriff (PDF)

Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model

Oncoimmunology, 2019-01, Vol.8 (1), p.e1512455-e1512455

2019

Volltextzugriff (PDF)

Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV

Journal of pediatric hematology/oncology, 2021-04, Vol.43 (3), p.e388-e394

2021

Volltextzugriff (PDF)

Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B‐NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

British journal of haematology, 2019-04, Vol.185 (2), p.374-377

2019

Volltextzugriff (PDF)

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

Blood, 2001-05, Vol.97 (10), p.2998-3003

2001

Volltextzugriff (PDF)

Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies

Expert review of anticancer therapy, 2003-08, Vol.3 (4), p.429-433

Goldman, Stanton C

2003

Volltextzugriff (PDF)

Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study

British journal of haematology, 2005-01, Vol.128 (1), p.49-58

2005

Volltextzugriff (PDF)

Patient Selection and Treatment of Tumor Lysis Syndrome in Adults with Hematologic Malignancies

Supportive cancer therapy, 2005-04, Vol.2 (3), p.167-167

Goldman, Stanton C.

2005

Volltextzugriff (PDF)

Excellent outcomes in children and adolescents with CNS + Burkitt lymphoma or other mature B‐ NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB / LMB 96 and COG ANHL 01P1

British journal of haematology, 2019-04, Vol.185 (2), p.374-377

2019

Volltextzugriff (PDF)

Abstract 2608: Ibrutinib significantly improves survival in a human Burkitt lymphoma (BL) xenograft NSG mouse model: Ibrutinib may be a potential adjuvant agent in the treatment of BL

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2608-2608

2015

Volltextzugriff (PDF)

Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patients

Journal of pediatric hematology/oncology, 2001-06, Vol.23 (5), p.300-305

2001

Volltextzugriff (PDF)

Abstract 4357: DLEU1 siRNA gene knockdown is associated with a significant reduction in cyclophosphamide (CY) and /or rituximab induced apoptosis in Burkitt lymphoma (BL): Implication of DLEU1 as a tumor suppressor gene

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4357-4357

2010

Volltextzugriff (PDF)

The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization

The American journal of pathology, 1996-05, Vol.148 (5), p.1381-1386

1996

Volltextzugriff (PDF)

Resistance to Monoclonal Antibody Therapeutics in Lymphoma

Resistance to Targeted Therapies in Lymphomas, 2019, Vol.21, p.27-55

2019

Volltextzugriff (PDF)

Monoclonal Antibody Therapy in Pediatrics: Initial Experiences With Rituximab

Journal of pediatric oncology nursing, 2001-03, Vol.18 (2), p.65-65

2001

Volltextzugriff (PDF)

A Longitudinal Investigation of Internalized Stigma, Constrained Disclosure, and Quality of Life Across 12 Weeks in Lung Cancer Patients on Active Oncologic Treatment

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1284-1293

2018

Volltextzugriff (PDF)

Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined with FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL

Blood, 2023-11, Vol.142 (Supplement 1), p.1727-1727

2023

Volltextzugriff (PDF)

Targeted Immunotherapy and Checkpoint Blockade in Children, Adolescents, and Young Adults with Lymphoma: Radical Hodgkin Cohort

Blood, 2023-11, Vol.142 (Supplement 1), p.3083-3083

2023

Volltextzugriff (PDF)

686 Targeted immunotherapy and checkpoint blockade in children, adolescents, and young adults with lymphoma: RADICAL hodgkin cohort

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A779-A779

2023

Volltextzugriff (PDF)

Polatuzumab Vedotin, an Antibody-Drug Conjugate Targeting CD79b, Is a Highly Active Agent Against Burkitt Lymphoma and Primary Mediastinal B-Cell Lymphoma

Blood, 2019-11, Vol.134 (Supplement_1), p.3963-3963

2019

Volltextzugriff (PDF)

Phase I Trial of VNP40101M (Cloretazine) in Children with Recurrent Brain Tumors: A Pediatric Brain Tumor Consortium Study

Clinical cancer research, 2008-02, Vol.14 (4), p.1124-1130

2008

Volltextzugriff (PDF)

Biological control of water pollution

1, 1976

Volltextzugriff (PDF)

Phase I Trial of VNP40101M (Cloretazine) in Children with Recurrent Brain Tumors : A Pediatric BrainTumor Consortium Study

Clinical cancer research, 2008, Vol.14 (4), p.1124-1130

2008

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Humans
(11)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Female
(8)
Male
(7)
Oncology
(7)
Adolescent
(6)
Biological And Medical Sciences
(6)
Child
(6)
Hematology
(6)
Medical Sciences
(6)
Child, Preschool
(5)
Infant
(5)
Adult
(4)
Treatment Outcome
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Chemotherapy
(3)
Children
(3)
Pharmacology. Drug Treatments
(3)
Antineoplastic Agents
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis

Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model

Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV

Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B‐NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies

Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study

Patient Selection and Treatment of Tumor Lysis Syndrome in Adults with Hematologic Malignancies

Excellent outcomes in children and adolescents with CNS + Burkitt lymphoma or other mature B‐ NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB / LMB 96 and COG ANHL 01P1

Abstract 2608: Ibrutinib significantly improves survival in a human Burkitt lymphoma (BL) xenograft NSG mouse model: Ibrutinib may be a potential adjuvant agent in the treatment of BL

Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patients

Abstract 4357: DLEU1 siRNA gene knockdown is associated with a significant reduction in cyclophosphamide (CY) and /or rituximab induced apoptosis in Burkitt lymphoma (BL): Implication of DLEU1 as a tumor suppressor gene

The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization

Resistance to Monoclonal Antibody Therapeutics in Lymphoma

Monoclonal Antibody Therapy in Pediatrics: Initial Experiences With Rituximab

A Longitudinal Investigation of Internalized Stigma, Constrained Disclosure, and Quality of Life Across 12 Weeks in Lung Cancer Patients on Active Oncologic Treatment

Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined with FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL

Targeted Immunotherapy and Checkpoint Blockade in Children, Adolescents, and Young Adults with Lymphoma: Radical Hodgkin Cohort

686 Targeted immunotherapy and checkpoint blockade in children, adolescents, and young adults with lymphoma: RADICAL hodgkin cohort

Polatuzumab Vedotin, an Antibody-Drug Conjugate Targeting CD79b, Is a Highly Active Agent Against Burkitt Lymphoma and Primary Mediastinal B-Cell Lymphoma

Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)

Phase I Trial of VNP40101M (Cloretazine) in Children with Recurrent Brain Tumors: A Pediatric Brain Tumor Consortium Study

Biological control of water pollution

Phase I Trial of VNP40101M (Cloretazine) in Children with Recurrent Brain Tumors : A Pediatric BrainTumor Consortium Study

Suchergebnisse filtern